News

Find News

Filter articles

Applied Filters

Showing 21 to 30 of 121 results

AstraZeneca sells Seroquel rights for $538m

China, UK10-05-2018

AstraZeneca has agreed to sell its rights to Seroquel (quetiapine fumarate) and Seroquel XR to China-based pharmaceutical company Luye Pharma Group for $538 million.

Celgene drops trademark claim against online pharmacies

India, US10-05-2018

Biopharmaceutical company Celgene has ditched its trademark quarrel with the owners of India-based online pharmacies importing generics into the US.

Merck KGaA secures CRISPR patent in China

China26-04-2018

China’s State Intellectual Property Office has granted Merck KGaA a patent covering its CRISPR technology used in a genomic-integration method for eukaryotic cells.

Takeda makes fourth offer to buy Shire

Ireland, Japan23-04-2018

Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.

China releases measures to boost pharma IP protection

China18-04-2018

China’s government has announced a series of measures to increase the country’s importation of drugs, including enhanced IP protection in the pharmaceutical industry.

China to slash tax for generic makers to 15%

China09-04-2018

China’s government has announced plans to implement preferential tax rates to generic drug makers in a bid to encourage the manufacturing of generics. 

Fujifilm makes $800m acquisition

Japan05-04-2018

Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.  

Eisai unites with Nichi-Iko to boost generics business

Japan03-04-2018

Eisai has partnered with fellow Japanese pharmaceutical company Nichi-Iko Pharmaceutical to expand and grow Nichi-Iko’s generic business.

Takeda mulls Shire acquisition bid

Ireland, Japan03-04-2018

Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.

Eisai partners with Merck for cancer drug R&D

China, US09-03-2018

Japanese pharmaceutical company Eisai has teamed up with US-based Merck in a deal intended to strengthen the worldwide development and commercialisation of cancer drug Lenvima.

Showing 21 to 30 of 121 results

LSIPR